• study of pharmacological properties of centrally acting molecules with potential application in treatment of psychiatric  diseases, neurodegenerative disorders and epilepsy, and as pain relievers,
• pharmacological properties (in vitro and in vivo tests) of newly synthesized compounds based on molecular mechanism of ligand-receptor interaction are specified in the frame of wide structure-affinity and structure-activity relationships studies (mainly behavioral tests on rodents).

• HPLC Waters Alliance 2695 Separation Module,
• Tail suspension stations for automatic assay (Campden Instruments Ltd.),
• Aron Apparatus (Bioseb),
• Elevated Plus - maze station for rats (Campden Instruments Ltd.),
• Motor monitor automatic system for rats (Campden Instruments Ltd.),
• Vogel Test System for rats (TSE),
• Opto-M3 Dual Axis 20 Cage System with 8 inch X axis sensors and 4 inch Y axis sensors for mice (Columbus Instruments),
• Hot plate analgesia for mice and rats (COMMAT LTD.),
• Elektroshoker generator for mice and rats (ugo basile s.r.l),
• Catalepsy - bar test for mice and rats,.

Methods and research techniques:

• mouse locomotor activity test  - Opto-M3 – 20 Cage system with inch X axis sensors and inch Y sensors for mice,
• the study of exploratory activity in rats - an automatic monitoring system,
• anticonvulsant activity - shock generator for mice and rats,
• the analgesic activity - hot plate in mice and rats,
• anxiolytic activity:
  • Vogel Test System for Rats, Elevated Plus-maze test for rats,
  • The antidepressant activity - studying the behavior of mice and rats in the forced swim test and the tail suspension,
• the behavior of mice and rats in the catalepsy test - a test rod.

• search for new psychotropic compounds e.g. selective ligands of receptors located in the central nervous system (as a tool for pharmacological studies) and/or compounds with multireceptor mechanism of action (as new drugs),
• behavioural study in rodents (mice, rats, guinea-pigs) of new compounds as potential:  antidepressants, anxiolytics, antipsychotics, antiepileptics, cognitive drugs, local and central acting analgetics. 

• collaboration with the pharmaceutical company Adamed,  the project: "Development of an innovative drug used in the treatment of central nervous system diseases: schizophrenia, depression and anxiety, preclinical studies." 
• behavioural study in rodents (mice, rats, guinea-pigs) of new compounds as potential:  antidepressants, anxiolytics, antipsychotics, antiepileptics, cognitive drugs, local and central acting analgetics.